Mark Forchette

Title: Mark Forchette: Innovator in Retinal Treatment Technologies

Introduction

Mark Forchette is a notable inventor based in Colleyville, TX (US). He has made significant contributions to the field of medical devices, particularly in the treatment of central retinal vein occlusions. His innovative approach has led to the development of a specialized device that addresses critical challenges in retinal surgery.

Latest Patents

Mark Forchette holds a patent for the "Laminar cribosa puncture device, methods related to use of such a device and methods for treating central retinal vein occlusions." This device is designed for puncturing tissue, specifically the lamina cribosa, and includes methods for treating central retinal vein occlusions. The puncturing device is configured to locally disrupt tissue at the puncture site, minimizing potential damage to adjacent body parts. This innovative design facilitates the perforation of tissue while ensuring the structural integrity of the central retinal vein is preserved.

Career Highlights

Mark Forchette is associated with Alcon Laboratories, Inc., a leading company in eye care products. His work at Alcon has allowed him to focus on developing advanced medical devices that improve patient outcomes in ophthalmology. With a patent portfolio that includes 1 patent, he has established himself as a key player in the field of retinal treatment technologies.

Collaborations

Throughout his career, Mark has collaborated with esteemed colleagues such as Donald J D'Amico and Eugene Lit. These partnerships have fostered innovation and have contributed to the advancement of medical technologies in the field of ophthalmology.

Conclusion

Mark Forchette's contributions to retinal treatment technologies exemplify the impact of innovation in medicine. His patented device represents a significant advancement in the treatment of central retinal vein occlusions, showcasing his commitment to improving patient care.